This resource provides practical articles on Cost Management Strategies and links to locate them. These articles are provided to assist pharmacy managers and directors in dealing with the management issues focused on the affordability and accessibility of pharmaceuticals. Current topics covered in this new resource section include pharmacists' intervention strategies, formulary management strategies, population-based strategies, and anti-infective management strategies. Additional strategies will be added periodically to assist managers and directors in managing high-cost issues in pharmacy.
Nesbit TW, Shermock KM, Bobek MB, Capozzi DL et. Al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacy practice model. Am J Health-Syst Pharm. 2001;58:784-90.
Skledar SJ, Hess MM. Implementation of a drug-use and disease-state management program. Am J Health-Syst Pharm 2000;57(suppl 4):S23-29.
Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000 Jun;20(6):609-21
Leape LL, Cullen DJ, Dempsey CM, et al. Pharmacists’ participation on physicians rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-270.
Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy service-1988–1995. Pharmacotherapy 1996; 16:1188–1208.
Hough A, Vartan CM, Groppi JA, Reyes S, et.al. Evaluation of clinical pharmacy interventions in a Veterans Affairs medical center primary care clinic. Am J Health Syst Pharm. 2013; 70:1168-1172.
Hamblin S, Rumbaugh K, Miller R. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach. J Trauma Acute Care Surg. 2012; 73(6):1484-1490.
Andrawis MA, Rehm SJ. Health-system pharmacists’ role in improving immunization rates. Am J Health Syst Pharm. 2012; 69:74-76.
Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, et.al. Economic effects of pharmacists on health outcomes in the United States: A systematic review. Am J health Syst Pharm. 2010; 67:1624-1634.
Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010; 30(4):330-338.
Perez A, Doloresco F, Hoffman JM, Meek PD, et.al. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy. 2009; 29(1):128.
Carter BL, Rogers M, Daly J, Zheng S, et.al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169(19):1748-1755.
Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009; 34(3):319-327.
De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: A literature review. Am J Health Syst Pharm. 2008; 65:1161-1172.
Kopp BJ, Mrsan M, Erstad B, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007; 64:2483-2487.
Murray MD, Young J, Hoke S, Tu W, et.al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007; 146(10):714-725.
Vivian EM. The pharmacist’s role in maintaining adherence to insulin therapy in type 2 diabetes mellitus. Consult Pharm. 2007; 22(4):320-332.
Sokos, DR. Pharmacists’ role in increasing pneumococcal and influenza vaccination. Am J Health Syst Pharm. 2005; 62:367-377.
Kucukarslan SN, Peters M, Miynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003; 163(17):2014-2018.
Borenstein JE, Graber G, Saltiel E, Wallace J, et.al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003; 23(2):209-216.
Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002; 22(12):1533-1540.